Alexia
4
1
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Ireadmore
Research Leaders
7 sponsors active, led by National Institute on Deafness and Other Communication Disorders (NIDCD)
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
ReadMap: Reading in Stroke Alexia and Typical Aging
Brain-based Understanding of Individual Language Differences After Stroke
Clinical Effectiveness of iReadMore for People With Alexia
Treatment for Reading and Writing Deficits Following Acquired Brain Injury
Research Network
Common Treatments
- Ireadmore1
- Multicomponent Reading And Writing Treatment1
Active Sponsors
- National Institute on Deafness and Other Communication Disorders (NIDCD)2
- MedStar National Rehabilitation Network2
- Georgetown University2
- Medical Research Council1
- University College, London1
Top Investigators
Georgetown University; MedStar National Rehabilitation Hospital
University College, London
Quality Living, Inc., Omaha, Nebraska
Related Conditions
- Stroke3
- Aphasia3
- Dementia1
- Acquired Brain Injury1
- Agraphia1